The NKG2D signaling pathway has already been implicated in other autoimmune disorders such as rheumatoid arthritis, giant cell arteritis, polymyalgia rheumatica, multiple sclerosis or Crohn's disease [13, 29-32]. This evidence concerns the gene KLRK1 and autoimmune disease.